Effect of diet or diet plus physical activity versus usual care on inflammatory markers in patients with newly diagnosed type 2 diabetes: The early activity in diabetes (ACTID) randomized, controlled trial

Journal of the American Heart Association

Volumn 3, Issue 3, 2014, Pages

  Thompson, Dylan ^a   Walhin, Jean Philippe ^a   Batterham, Alan M ^b   Stokes, Keith A ^a   Cooper, Ashley R ^c,d   Andrews, Robert C ^c  

^a University of Bath   (United Kingdom)

^b TEESSIDE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d Queen Mary University of London and Barts NIHR BRC NHS Trust National Institute for Health and Care Research   (United Kingdom)

Author keywords

Cardiovascular disease; Exercise; Inflammation; Physical activity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET; FEMALE; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT CARE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIET THERAPY; KINESIOTHERAPY; MIDDLE AGED; MOTOR ACTIVITY; MULTIMODALITY CANCER THERAPY;

ADIPONECTIN; BIOMARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; EXERCISE THERAPY; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MOTOR ACTIVITY;

EID: 84913605185     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.000828     Document Type: Article

References (37)

1. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease application to clinical and public health practice-a statement for healthcare professionals from the Centers for Disease Control and prevention and the American Heart Association. Circulation. 2003;107:499-511.
2. Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, Brook GJ, Levy Y. Association between fasting glucose and c-reactive protein in middleaged subjects. Diabet Med. 2004;21:39-44.
3. Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB. C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care. 2004;27:889-894.
4. Schillinger M, Exner M, Amighi J, Mlekusch W, Sabeti S, Rumpold H, Wagner O, Minar E. Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation. 2003;108:2323-2328.
5. Stehouwer CDA, Gall MA, Twisk JWR, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic lowgrade inflammation in type 2 diabetes-progressive, interrelated, and independently associated with risk of death. Diabetes. 2002;51:1157-1165.
6. Kang ES, Kim HJ, Kim YM, Lee S, Cha BS, Lim SK, Kim HJ, Lee HC. Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes. Diabetes Res Clin Pract. 2004;66(suppl):S115-S120.
7. Yu HI, Sheu WHH, Song YM, Liu HC, Lee WJ, Chen YT. C-reactive protein and risk factors for peripheral vascular disease in subjects with type 2 diabetes mellitus. Diabet Med. 2004;21:336-341.
8. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193-203.
9. Kadoglou NPE, Fotiadis G, Kapelouzou A, Kostakis A, Liapis CD, Vrabas IS. The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with type 2 diabetes. Diabet Med. 2013;30:e41-e50.
10. Jorge MLMP, de Oliveira VN, Resende NM, Paraiso LF, Calixto A, Diniz ALD, Resende ES, Ropelle ER, Carvalheira JB, Espindola FS, Jorge PT, Geloneze B. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism. 2011;60:1244-1252.
11. Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu M-Y, Smith EOB, Nelson KW, Ballantyne CM. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab. 2004;89:2697-2703.
12. Balducci S, Zanuso S, Nicolucci A, De Feo P, Cavallo S, Cardelli P, Fallucca S, Alessi E, Fallucca F, Pugliese G. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). Arch Intern Med. 2010;170:1794-1803.
13. Belalcazar LM, Haffner SM, Lang W, Hoogeveen RC, Rushing J, Schwenke DC, Tracy RP, Pi-Sunyer FX, Kriska AM, Ballantyne CM; The Look AHEAD (Action For Health In Diabetes) Research Group. Lifestyle intervention and/or statins for the reduction of c-reactive protein in type 2 diabetes: from the look AHEAD study. Obesity. 2013;21:944-950.
14. Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, Jackson N, Fitzsimons K, Bright J, Coulman K, England CY, Gorton J, McLenaghan A, Paxton E, Polet A, Thompson C, Dayan CM. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the early actid randomised controlled trial. Lancet. 2011;378:129-139.
15. Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, Engert JC, Clarke R, Davey-Smith G, Nordestgaard BG, Saleheen D, Samani NJ, Sandhu M, Anand S, Pepys MB, Smeeth L, Whittaker J, Casas JP, Thompson SG, Hingorani AD, Danesh J, Collaboration C. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data; Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC). BMJ. 2011;342:d548.
16. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82:4196-4200.
17. Schulze MB, Rifai N, Rimm EB, Hu FB, Shai I. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care. 2004;27:1680-1687.
18. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. J Am Med Assoc. 2004;291:1730-1737.
19. Shai I, Pischon T, Hu FB, Ascherio A, Rifai N, Rimm EB. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease. Obesity. 2006;14:2099-2106.
20. Kanai A, Kawamura T, Umemura T, Nagashima M, Nakamura N, Nakayama M, Sano T, Nakashima E, Hamada Y, Nakamura J, Hotta N. Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and c-reactive protein in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2008;82:157-164.
21. Perneger TV. What's wrong with bonferroni adjustments. Br Med J. 1998;316:1236-1238.
22. Altman DG. Confidence intervals for the number needed to treat. Br Med J. 1998;317:1309-1312.
23. Keene ON. The log transformation is special. Stat Med. 1995;14:811-819.
24. Enders CK, Bandalos DL. The relative performance of full information maximum likelihood estimation for missing data in structural equation models. Struct Equ Model Multi J. 2001;8:430-457.
25. White IR, Thompson SG. Adjusting for partially missing baseline measurements in randomized trials. Stat Med. 2005;24:993-1007.
26. Hopkins W, Marshall S, Batterham A, Hanin Y. Progressive statistics for studies in sports medicine and exercise. Med Sci Sports Exerc. 2009;41:3-12.
27. Dandona P. Effects of antidiabetic and antihyperlipidemic agents on c-reactive protein. Mayo Clin Proc. 2008;83:333-342.
28. Dixon NC, Hurst TL, Talbot DCS, Tyrrell RM, Thompson D. Effect of short-term reduced physical activity on cardiovascular risk factors in active lean and overweight middle-aged men. Metabolism. 2013;62:361-368.
29. Mora S, Lee IM, Buring JE, Ridker PM. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. J Am Med Assoc. 2006;295:1412-1419.
30. Hansen D, Dendale P, Beelen M, Jonkers RAM, Mullens A, Corluy L, Meeusen R, van Loon LJC. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Eur J Appl Physiol. 2010;109:397-404.
31. Fisher G, Hyatt TC, Hunter GR, Oster RA, Desmond RA, Gower BA. Effect of diet with and without exercise training on markers of inflammation and fat distribution in overweight women. Obesity. 2011;19:1131-1136.
32. Church TS, Earnest CP, Thompson AM, Priest EL, Rodarte RQ, Saunders T, Ross R, Blair SN. Exercise without weight loss does not reduce c-reactive protein: the inflame study. Med Sci Sports Exerc. 2010;42:708-716.
33. Thompson D, Markovitch D, Betts JA, Mazzatti D, Turner J, Tyrrell RM. Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial. J Appl Physiol. 2010;108:769-779.
34. Stewart LK, Earnest CP, Blair SN, Church TS. Effects of different doses of physical activity on c-reactive protein among women. Med Sci Sports Exerc. 2010;42:701-707.
35. Thompson D, Karpe F, Lafontan M, Frayn KN. Physical activity and exercise in the regulation of human adipose tissue physiology. Physiol Rev. 2012;92:157-191.
36. Thompson D, Batterham AM, Bock S, Robson C, Stokes K. Assessment of lowto-moderate intensity physical activity thermogenesis in young adults using synchronized heart rate and accelerometry with branched-equation modeling. J Nutr. 2006;136:1037-1042.
37. Solomon TPJ, Malin SK, Karstoft K, Haus JM, Kirwan JP. The influence of hyperglycemia on the therapeutic effect of exercise on glycemic control in patients with type 2 diabetes mellitus. JAMA Intern Med. 2013;173:1834-1836.